1. ALLA AKTIER
  2. NYHETER
  3. DICOT

Dicot

Nyheter Dicot Nyheter alla bolag

Letters of Intent from Major Shareholders, Board, and Management to Subscribe for SEK 11 million in Dicot Pharma's TO 6, Running Until March 31, 2025

REG

"It is very pleasing that we are once again seeing strong support from our major shareholders, board and management. This confidence means a lot and it feels extra valuable to be able to announce this even before the subscription period has begun", says Elin Trampe, CEO.

 

One warrant of series TO 6 entitles to subscribe for two new shares at SEK 0.19 per share. To prevent the warrants from expiring worthless, the holder must actively subscribe for shares by March 31, 2025, or alternatively sell the warrants by March 27, 2025.

If all warrants are exercised for the subscription of new shares, Dicot Pharma will receive approximately SEK 45.7 million before issuance costs.

The terms and conditions regarding the warrants are available on Dicot Pharma's website www.dicotpharma.com.

 

Datum 2025-03-13, kl 11:50
Källa Cision
Bifogade filer
Dicot Pharma, Letters of Intent to subscribe for SEK 11 million in TO 6
Affiliate
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.